![Peter Pitts](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
Peter Joe Pitts is currently an Independent Director at Painscript Corp., an Independent Non-Executive Director at Ambio Pharmaceuticals Inc since 2021, an Independent Director at Brainstorm Cell Therapeutics, Inc. starting in 2026, and President of The Center for Medicine in the Public Interest since 2004.
Former positions include Director-Global Regulatory & Health Policy at Porter Novelli, Inc., Independent Director at Ambio Holdings, Inc., and Associate Commissioner-External Relations at the US Food & Drug Administration from 2002 to 2004.
Education includes an undergraduate degree from McGill University, conferred in 1981.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 25/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Direttore/Membro del Consiglio | 25/05/2026 |
Painscript Corp.
 Painscript Corp. Internet Software/ServicesTechnology Services Provides medical treatment compliance platform services | Direttore/Membro del Consiglio | - |
Ambio Pharmaceuticals
 Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Direttore/Membro del Consiglio | 08/10/2020 |
The Center for Medicine in the Public Interest
 The Center for Medicine in the Public Interest Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit, nonpartisan research and educational organization for patient-centered health care | Presidente | 01/01/2004 |
| Società | Posizione | Fine |
|---|---|---|
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 01/01/2004 |
Ambio Holdings, Inc.
 Ambio Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a contract development and manufacturing organization focused on peptide active pharmaceutical ingredients | Direttore/Membro del Consiglio | - |
Porter Novelli, Inc.
 Porter Novelli, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public relations services | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Brainstorm Cell Therapeutics, Inc.
 Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
Porter Novelli, Inc.
Porter Novelli, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public relations services | Commercial Services |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Ambio Holdings, Inc.
Ambio Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a contract development and manufacturing organization focused on peptide active pharmaceutical ingredients | Health Technology |
The Center for Medicine in the Public Interest
The Center for Medicine in the Public Interest Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit, nonpartisan research and educational organization for patient-centered health care | Commercial Services |
Painscript Corp.
Painscript Corp. Internet Software/ServicesTechnology Services Provides medical treatment compliance platform services | Technology Services |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
